The role of mutators in the emergence of antibiotic-resistant bacteria

Drug Resistance Updates

Volumn 6, Issue 3, 2003, Pages 137-145

  Chopra, Ian ^a   O'Neill, Alexander J ^a   Miller, Keith ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Antibiotic resistance; Bacterial fitness; Bacterial mutators; Methyl directed mismatch repair; Mutation frequencies

Indexed keywords

ANTIBIOTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; EPIGALLOCATECHIN; RIFAMPICIN; TANNIN; TAURINE; VANILLIN;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM MUTANT; CELL DENSITY; ESCHERICHIA COLI; GENE TRANSFER; HELICOBACTER PYLORI; MISMATCH REPAIR; MUTS GENE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; RISK FACTOR; SALMONELLA ENTERICA; STREPTOCOCCUS PNEUMONIAE;

EID: 0037699291     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-7646(03)00041-4     Document Type: Short Survey

References (70)

1. Alonso, A., Campanario, E., Martinez, J.L., 1999. Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. Microbiology (UK) 145, 2857-2862.
2. Avison, M.B., Bennett, P.M., Howe, R.A., et al., 2002. Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50. J. Antimicrob. Chemother. 49, 255-260.
3. Bannon, J., Hatem, M.H., Noone, M., 1998. Anaerobic infections of the urinary tract: are they being missed? J. Clin. Pathol. 51, 709-710.
4. Baquero, F., 2001. Low-level antibacterial resistance: a gateway to clinical resistance. Drug Resist. Update 4, 93-105.
5. Bayliss, C.D., Moxon, E.R., 2002. Hypermutation and bacterial adaptation. ASM News 68, 549-555.
6. Bjorkholm, B., Sjolund, M., Falk, P.G., et al., 2001. Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proc. Natl. Acad. Sci. U.S.A. 98, 14607-14612.
7. Boe, L., Danielsen, M., Knudsen, S., et al., 2000. The frequency of mutators in populations of Escherichia coli. Mutat. Res. Fundam. Mol. Mech. Mutagen. 448, 47-55.
8. Bridges, B.A., 2001. Hypermutation in bacteria and other cellular systems. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 356, 29-39.
9. Brown, E.W., LeClerc, J.E., Li, B.G., et al., 2001. Phylogenetic evidence for horizontal transfer of mutS alleles among naturally occurring Escherichia coli strains. J. Bacteriol. 183, 1631-1644.
10. Bullions, L.C., Mejean, V., Claverys, J.P., et al., 1994. Purification of the MutX protein of Streptococcus pneumoniae, a homolog of Escherichia coli MutT - identification of a novel catalytic domain for nucleoside triphosphate pyrophosphohydrolase activity. J. Biol. Chem. 269, 12339-12344.
11. Bush, K., 2001. New beta-lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin. Infect. Dis. 32, 1085-1089.
12. Coates, A., Hu, Y.M., Bax, R., et al., 2002. The future challenges facing the development of new antimicrobial drugs. Nat. Rev. Drug Discov. 1, 895-910.
13. Davies, J., 1994. Inactivation of antibiotics and the dissemination of resistance genes. Science 264, 375-382.
14. de Visser, J.A.G.M., 2002. The fate of microbial mutators. Microbiology 148, 1247-1252.
15. Denamur, E., Bonacorsi, S., Giraud, A., et al., 2002. High frequency of mutator strains among human uropathogenic Escherichia coli isolates. J. Bacteriol. 184, 605-609.
16. Feng, G., Tsui, H.C.T., Winkler, M.E., 1996. Depletion of the cellular amounts of the MutS and MutH methyl-directed mismatch repair proteins in stationary-phase Escherichia coli K-12 cells. J. Bacteriol. 178, 2388-2396.
17. Funchain, P., Yeung, A., Stewart, J.L., et al., 2000. The consequences of growth of a mutator strain of Escherichia coli as measured by loss of function among multiple gene targets and loss of fitness. Genetics 154, 959-970.
18. Galan, J.C., Baquero, M.R., Reig, M., et al., 2000. Use of a mutator MutS - AmpC - E. coli host-strain to predict the appearance of clavulanate-resistant ACI-1 β-lactamase in Acidaminococcus (abstract). In: 40th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Toronto, Canada.
19. Ginetti, F., Perego, M., Albertini, A.M., et al., 1996. Bacillus subtilis mutS mutL operon: identification, nucleotide sequence and mutagenesis. Microbiology 142, 2021-2029.
20. Giraud, A., Matic, I., Tenaillon, O., et al., 2001. Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut. Science 291, 2606-2608.
21. Giraud, A., Matic, I., Radman, M., et al., 2002. Mutator bacteria as a risk factor in treatment of infectious diseases. Antimicrob. Agents Chemother. 46, 863-865.
22. Godfrey, H.P., Bugrysheva, J.V., Cabello, F.C., 2002. The role of the stringent response in the pathogenesis of bacterial infections. Trends Microbiol. 10, 349-351.
23. Harris, R.S., Feng, G., Ross, K.J., et al., 1999. Mismatch repair is diminished in stationary-phase mutation. Mutat. Res. 437, 51-60.
24. Hogan, D., Kolter, R., 2002. Why are bacteria refractory to antimicrobials? Curr. Opin. Microbiol. 5, 472-477.
25. Horst, J.P., Wu, T.H., Marinus, M.G., 1999. Escherichia coli mutator genes. Trends Microbiol. 7, 29-36.
26. Hughes, D., Andersson, D.I., 1997. Carbon starvation of Salmonella typhimurium does not cause a general increase of mutation rates. J. Bacteriol. 179, 6688-6691.
27. Karunakaran, P., Davies, J., 2000. Genetic antagonism and hypermutability in Mycobacterium smegmatis. J. Bacteriol. 182, 3331-3335.
28. Kuroda, Y., Hara, Y., 1999. Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat. Res. Rev. Mutat. Res. 436, 69-97.
29. LeClerc, J.E., Li, B.G., Payne, W.L., et al., 1996. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274, 1208-1211.
30. LeClerc, J.E., Payne, W.L., Kupchella, E., et al., 1998. Detection of mutator subpopulations in Salmonella typhimurium LT2 by reversion of his alleles. Mutat. Res. Fundam. Mol. Mech. Mutagen. 400, 89-97.
31. Livermore, D.M., 2003. Bacterial resistance: origins, epidemiology, and impact. Clin. Infect. Dis. 36, S11-S23.
32. Mao, E.F., Lane, L., Lee, J., et al., 1997. Proliferation of mutators in a cell population. J. Bacteriol. 179, 417-422.
33. Martinez, J.L., 1995. On complexity and simplicity as different evolutionary strategies. Evol. Theory 10, 317-320.
34. Martinez, J.L., Baquero, F., 2002. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin. Microbiol. Rev. 15, 647-679.
35. Merino, D., Reglier-Poupet, H., Berche, P., et al., 2002. A hypermutator phenotype attenuates the virulence of Listeria monocytogenes in a mouse model. Mol. Microbiol. 44, 877-887.
36. Miller, J.H., 1996. Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair. Annu. Rev. Microbiol. 50, 625-643.
37. Miller, J.H., Suthar, A., Tai, J., et al., 1999. Direct selection for mutators in Escherichia coli. J. Bacteriol. 181, 1576-1584.
38. Miller, K., O'Neill, A.J., Chopra, I., 2002. Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes. J. Antimicrob. Chemother. 49, 925-934.
39. Mobashery, S., Azucena, E.F., 1999. Bacterial Antibiotic Resistance. Nature Publishing Group, London. http://www.els.net.
40. Modrich, P., 1989. Methyl-directed DNA mismatch correction. J. Biol. Chem. 264, 6597-6600.
41. Modrich, P., Lahue, R., 1996. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu. Rev. Biochem. 65, 101-133.
42. Morosini, M.I., Baquero, M.R., Sanchez-Romero, J.M., et al., 2003. Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation. Antimicrob. Agents Chemother. 47, 1464-1467.
43. Negri, M.C., Morosini, M.I., Baquero, M.R., et al., 2002. Very low cefotaxime concentrations select for hypermutable Streptococcus pneumoniae populations. Antimicrob. Agents Chemother. 46, 528-530.
44. Notley-McRobb, L., Seeto, S., Ferenci, T., 2002. Enrichment and elimination of mutY mutators in Escherichia coli populations. Genetics 162, 1055-1062.
45. Novick, R.P., 1991. Genetic systems in staphylococci. Methods Enzymol. 204, 587-636.
46. O'Grady, F., Lambert, H.P., Finch, R.G., et al., 1997. Antibiotic and Chemotherapy, 7th ed. Churchill Livingstone, New York.
47. Oliver, A., Canton, R., Campo, P., et al., 2000. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288, 1251-1253.
48. Oliver, A., Baquero, F., Blazquez, J., 2002. The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Mol. Microbiol. 43, 1641-1650.
49. O'Neill, A.J., Chopra, I., 2002. Insertional inactivation of mutS in Staphylococcus aureus reveals potential for elevated mutation frequencies, although the prevalence of mutators in clinical isolates is low. J. Antimicrob. Chemother. 50, 161-169.
50. O'Neill, A.J., Chopra, I., 2003. Lack of evidence for involvement of hypermutability in emergence of vancomycin-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 47, 1484-1485.
51. Orencia, M.C., Yoon, J.S., Ness, J.E., et al., 2001. Predicting the emergence of antibiotic resistance by directed evolution and structural analysis. Nat. Struct. Biol. 8, 238-242.
52. Pillai, S.P., Shankel, D.M., 1998. Effects of antimutagens on development of drug/antibiotic resistance in microorganisms. Mutat. Res. Fundam. Mol. Mech. Mutagen. 402, 139-150.
53. Pillai, S.P., Pillai, C.A., Shankel, D.M., et al., 2001. The ability of certain antimutagenic agents to prevent development of antibiotic resistance. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 496, 61-73.
54. Rayssiguier, C., Thaler, D.S., Radman, M., 1989. The barrier to recombination between Escherichia coli and Salmonella typhimurium is disrupted in mismatch-repair mutants. Nature 342, 396-401.
55. Richardson, A.R., Yu, Z., Popovic, T., et al., 2002. Mutator clones of Neisseria meningitidis in epidemic serogroup A disease. Proc. Natl. Acad. Sci. U.S.A. 99, 6103-6107.
56. Russell, A.D., Chopra, I., 1996. Understanding Antibacterial Action and Resistance, 2nd ed. Ellis Horwood, Hertfordshire.
57. Schaaff, F., Reipert, A., Bierbam, G., 2002. An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 46, 3540-3548.
58. Shibutani, S., Takeshita, M., Grollman, A.P., 1991. Insertion of specific bases during DNA-synthesis past the oxidation-damaged base 8-oxodg. Nature 349, 431-434.
59. Sniegowski, P.D., Gerrish, P.J., Lenski, R.E., 1997. Evolution of high mutation rates in experimental populations of E. coli. Nature 387, 703-705.
60. Stambuk, S., Radman, M., 1998. Mechanism and control of interspecies recombination in Escherichia coli. I. Mismatch repair, methylation, recombination and replication functions. Genetics 150, 533-542.
61. Taddei, F., Matic, I., Radman, M., 1995. Camp-dependent SOS induction and mutagenesis in resting bacterial-populations. Proc. Natl. Acad. Sci. U.S.A. 92, 11736-11740.
62. Taddei, F., Radman, M., Maynard-Smith, J., et al., 1997. Role of mutator alleles in adaptive evolution. Nature 387, 700-702.
63. Tanabe, K., Kondo, T, Onodera, Y., et al., 1999. A conspicuous adaptability to antibiotics in the Escherichia coli mutator strain, dnaQ49. FEMS Microbiol. Lett. 176, 191-196.
64. Tenaillon, O., Toupance, B., Le Nagard, H., et al., 1999. Mutators, population size, adaptive landscape and the adaptation of asexual populations of bacteria. Genetics 152, 485-493.
65. Trobner, W., Piechocki, R., 1984. Selection against hypermutability in Escherichia coli during long-term evolution. Mol. Gen. Genet. 198, 177-178.
66. Tsui, H.C.T., Feng, G., Winkler, M.E., 1997. Negative regulation of mutS and mutH repair gene expression by the Hfq and RpoS global regulators of Escherichia coli K-12. J. Bacteriol. 179, 7476-7487.
67. Watson, J.D., Hopkins, N.H., Roberts, J.W., et al., 1987. Molecular Biology of the Gene, 4th ed. The Benjamin/Cummings Publishing Company, Inc., Menlo Park, CA, USA.
68. Wright, B.E., 1996. The effect of the stringent response on mutation rates in Escherichia coli K-12. Mol. Microbiol. 19, 213-219.
69. Wright, B.E., 1997. Does selective gene activation direct evolution? FEBS Lett. 402, 4-8.
70. Yonezawa, Y., Kawamura, S., Yamato, M., et al., 2001. Mut-test to detect substances suppressing spontaneous mutation due to oxidative damage. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 490, 21-26.